The Latest in ICYMI Multiple Sclerosis

Drugs for Progressive MS Could Target Multiple Disease Mechanisms

March 22, 2016

Multiple Sclerosis

Evidence builds for mesenchymal stem cell therapy in MS

March 7, 2016

Multiple Sclerosis

High coffee consumption linked to decreased risk for MS

March 3, 2016

Multiple Sclerosis

BENEFIT 11: No new safety signals with interferon beta-1b

March 2, 2016

Multiple Sclerosis

Study examines efficacy of small group programs for fatigue in MS

March 2, 2016

Multiple Sclerosis

L-Selectin May Not Predict PML Risk Accurately

February 29, 2016

Multiple Sclerosis

Proposal Requires Three Lesions for Diagnosis of MS

February 29, 2016

Multiple Sclerosis

Phenytoin May Offer Neuroprotection to Patients With Optic Neuritis

February 29, 2016

Multiple Sclerosis

Natalizumab May Increase Risk of JCV Seroconversion

February 29, 2016

Multiple Sclerosis

Stem cell therapy for MS: Steady progress but not ready for general use

February 28, 2016

Multiple Sclerosis

Brain atrophy may be a clinically relevant measure in PPMS: Data from INFORMS

February 26, 2016

Multiple Sclerosis

Triage MS-related ED visits to reduce unnecessary treatment

February 26, 2016

Multiple Sclerosis

Fingolimod improved gait impairment in small study

February 26, 2016

Multiple Sclerosis

VIDEO: Novel tools measure disease progression in MS

February 25, 2016

Multiple Sclerosis

Positive headway reported for progressive multiple sclerosis

February 25, 2016

Multiple Sclerosis